Volume 28 - Issue 9 - September 2020
Cover Story
09/11/2020
Bullying is common in childhood, and children with visible skin conditions can be highly vulnerable. Dermatologists can play a critical role into helping their pediatric patients through early screening and management.
Bullying is common in childhood, and children with visible skin conditions can be highly vulnerable. Dermatologists can play a critical role into helping their pediatric patients through early screening and management.
Bullying is common in childhood,...
09/11/2020
The Dermatologist
Department
Business Insider
10/05/2020
Practice valuation nomenclature has changed over the years. Practice values used to be referred to as a percentage of collections, but today’s most common reference point is a multiple of earnings before interest,...
Practice valuation nomenclature has changed over the years. Practice values used to be referred to as a percentage of collections, but today’s most common reference point is a multiple of earnings before interest,...
...
10/05/2020
The Dermatologist
Derm Dx
09/11/2020
A 67-year-old Ethiopian woman presented with a large black plaque surrounded by several smaller violaceous papules on her frontal hairline for 6 months (Figure). The largest plaque was tender and occasionally...
A 67-year-old Ethiopian woman presented with a large black plaque surrounded by several smaller violaceous papules on her frontal hairline for 6 months (Figure). The largest plaque was tender and occasionally...
A...
09/11/2020
The Dermatologist
Letters to the Editor
09/11/2020
It’s wonderful to see this discussion about value-based care models (VBCMs). I appreciate Dr Buka’s response to my article1 and thanks to Ms Brillstein for continuing the dialogue.2
I agree with Ms Brillstein...
It’s wonderful to see this discussion about value-based care models (VBCMs). I appreciate Dr Buka’s response to my article1 and thanks to Ms Brillstein for continuing the dialogue.2
I agree with Ms Brillstein...
It’s...
09/11/2020
The Dermatologist
Feature
Feature Story
09/11/2020
Patients are savvier than ever when selecting their dermatologist. This cross-sectional study of a provider review website set out to determine what factors affect patient satisfaction.
Patients are savvier than ever when selecting their dermatologist. This cross-sectional study of a provider review website set out to determine what factors affect patient satisfaction.
Patients are savvier than ever...
09/11/2020
The Dermatologist
Feature Story
09/11/2020
Infection with hepatitis C (HCV) predisposes to both development and exacerbation of porphyria cutanea tarda (PCT). However, antiviral therapy for HCV has classically been deferred in patients with PCT until after...
Infection with hepatitis C (HCV) predisposes to both development and exacerbation of porphyria cutanea tarda (PCT). However, antiviral therapy for HCV has classically been deferred in patients with PCT until after...
...
09/11/2020
The Dermatologist
Feature Story
09/11/2020
Infection with hepatitis C (HCV) predisposes to both development and exacerbation of porphyria cutanea tarda (PCT). However, antiviral therapy for HCV has classically been deferred in patients with PCT until after...
Infection with hepatitis C (HCV) predisposes to both development and exacerbation of porphyria cutanea tarda (PCT). However, antiviral therapy for HCV has classically been deferred in patients with PCT until after...
...
09/11/2020
The Dermatologist
Partner Approved
09/11/2020
Lynn McKinley-Grant, MD, FAAD details what you need to remember when diagnosing and treating psoriasis in patients of color.
Lynn McKinley-Grant, MD, FAAD details what you need to remember when diagnosing and treating psoriasis in patients of color.
Lynn McKinley-Grant, MD, FAAD...
09/11/2020
The Dermatologist
Partner Approved
09/11/2020
New biologic therapy tralokinumab, a human monoclonal antibody targeting IL-13, is under FDA review for the treatment of atopic dermatitis.
New biologic therapy tralokinumab, a human monoclonal antibody targeting IL-13, is under FDA review for the treatment of atopic dermatitis.
New biologic therapy...
09/11/2020
The Dermatologist
Feature Story
09/11/2020
Telehealth may have a time and place in dermatology, but the quality and efficiency of the in-person visit can never be replaced.
Telehealth may have a time and place in dermatology, but the quality and efficiency of the in-person visit can never be replaced.
Telehealth may have a time and...
09/11/2020
The Dermatologist
Partner Approved
09/11/2020
New biologic therapy tralokinumab, a human monoclonal antibody targeting IL-13, is under FDA review for the treatment of atopic dermatitis.
New biologic therapy tralokinumab, a human monoclonal antibody targeting IL-13, is under FDA review for the treatment of atopic dermatitis.
New biologic therapy...
09/11/2020
The Dermatologist
